ZA200905690B - Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant - Google Patents
Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectantInfo
- Publication number
- ZA200905690B ZA200905690B ZA200905690A ZA200905690A ZA200905690B ZA 200905690 B ZA200905690 B ZA 200905690B ZA 200905690 A ZA200905690 A ZA 200905690A ZA 200905690 A ZA200905690 A ZA 200905690A ZA 200905690 B ZA200905690 B ZA 200905690B
- Authority
- ZA
- South Africa
- Prior art keywords
- peg
- interferon alpha
- alpha conjugates
- cryoprotectant
- raffinose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN412MU2007 | 2007-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200905690B true ZA200905690B (en) | 2010-05-26 |
Family
ID=39592752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200905690A ZA200905690B (en) | 2007-03-05 | 2009-08-17 | Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2117514B1 (xx) |
JP (1) | JP5179521B2 (xx) |
AT (1) | ATE512660T1 (xx) |
BR (1) | BRPI0808259A2 (xx) |
EA (1) | EA019345B1 (xx) |
ES (1) | ES2365832T3 (xx) |
WO (1) | WO2008107908A1 (xx) |
ZA (1) | ZA200905690B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0313806A (pt) | 2002-08-26 | 2005-07-05 | Pfizer Prod Inc | Vacinas para infecções nos sistemas respiratório e reprodutor em gado |
WO2010064258A2 (en) * | 2008-12-01 | 2010-06-10 | Intas Biopharmaceuticals Limited | Pharmaceutical formulations of interferon conjugates |
US20100196272A1 (en) * | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
US20140017318A1 (en) * | 2012-07-10 | 2014-01-16 | Kevin O'Connell | Method to produce a medicinal product comprising a biologically active protein and the resulting product |
BR112015009453A2 (pt) * | 2012-10-26 | 2017-07-04 | Lupin Ltd | composição farmacêutica estável de peg-interferona alfa-2b |
AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4242863A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF |
CN1073119C (zh) * | 1994-05-18 | 2001-10-17 | 吸入治疗系统公司 | 干扰素干粉配方的方法及组合物 |
BR9809304B1 (pt) * | 1997-04-28 | 2011-02-08 | formulação liofilizada estável, processo para preparação da mesma, bem como forma de dosagem unitária. | |
US6180096B1 (en) * | 1998-03-26 | 2001-01-30 | Schering Corporation | Formulations for protection of peg-interferon alpha conjugates |
AU777972B2 (en) * | 1999-02-22 | 2004-11-04 | Baxalta GmbH | Novel albumin-free factor VIII formulations |
JP2004511428A (ja) * | 2000-05-24 | 2004-04-15 | イーライ・リリー・アンド・カンパニー | 凝固亢進状態を処置するための製剤および方法 |
CN1744918A (zh) * | 2002-12-31 | 2006-03-08 | 尼克塔治疗亚拉巴马公司 | 含有酮或相关官能团的聚合物试剂 |
EP1734988A4 (en) * | 2004-03-01 | 2009-08-05 | Enzon Pharmaceuticals Inc | INTERFERON BETA-polymer |
JP4971160B2 (ja) | 2004-08-12 | 2012-07-11 | シェーリング コーポレイション | 安定するpeg化インターフェロン処方物 |
-
2008
- 2008-02-29 ES ES08720138T patent/ES2365832T3/es active Active
- 2008-02-29 WO PCT/IN2008/000114 patent/WO2008107908A1/en active Application Filing
- 2008-02-29 EP EP08720138A patent/EP2117514B1/en active Active
- 2008-02-29 BR BRPI0808259-6A2A patent/BRPI0808259A2/pt not_active IP Right Cessation
- 2008-02-29 EA EA200970831A patent/EA019345B1/ru not_active IP Right Cessation
- 2008-02-29 JP JP2009552329A patent/JP5179521B2/ja not_active Expired - Fee Related
- 2008-02-29 AT AT08720138T patent/ATE512660T1/de not_active IP Right Cessation
-
2009
- 2009-08-17 ZA ZA200905690A patent/ZA200905690B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010520270A (ja) | 2010-06-10 |
ES2365832T3 (es) | 2011-10-11 |
BRPI0808259A2 (pt) | 2014-07-08 |
EP2117514B1 (en) | 2011-06-15 |
EA019345B1 (ru) | 2014-03-31 |
ATE512660T1 (de) | 2011-07-15 |
EA200970831A1 (ru) | 2010-02-26 |
JP5179521B2 (ja) | 2013-04-10 |
WO2008107908A1 (en) | 2008-09-12 |
EP2117514A1 (en) | 2009-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200905690B (en) | Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant | |
JOP20180102B1 (ar) | مركب صيدلاني | |
WO2008062481A3 (en) | Formulations of peg-interferon alpha conjugates | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
MX2010010508A (es) | Composiciones de absorcion de sebo. | |
HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
EA201190306A1 (ru) | Улучшенная липидная композиция | |
MX2010005889A (es) | Derivados de tiofeno como agonistas de s1p1/edg1. | |
MY159940A (en) | Detergent composition comprising a variant of a family 44 xyloglucanase | |
MX2011012523A (es) | Esteres cetalicos de anhidropentitoles y usos de los mismos. | |
MX339060B (es) | Formulaciones del factor viii. | |
MX2012005782A (es) | Procedimientos, composiciones y kits de liofilizacion. | |
TN2009000398A1 (en) | 5,6-dihydro-1h-pyridin-2-one compounds | |
EA201590705A1 (ru) | ПОЛУЧЕНИЕ РЕКОМБИНАНТНОЙ ВАКЦИНЫ В E.coli ПОСРЕДСТВОМ ЭНЗИМАТИЧЕСКОЙ КОНЪЮГАЦИИ | |
NZ706052A (en) | Romidepsin solid forms and uses thereof | |
TN2010000074A1 (en) | Cyclic depsipeptides | |
HK1133642A1 (en) | Azaadamantane ester and carbamate derivatives and methods of use thereof | |
TN2009000447A1 (en) | An extented-release composition comprising a somatostatin derivative in microparticles | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
NO20074536L (no) | Anvendelse av jern (III)-komplekssammensetninger | |
MX2022001719A (es) | Formulaciones de conjugados de benzazepina y usos de las mismas. | |
PE20142325A1 (es) | Composiciones derivadas de la quitosana | |
EA201070484A1 (ru) | Новые конъюгаты нейртурина для фармацевтического применения | |
GB0812006D0 (en) | Organic compounds | |
MX2010003914A (es) | Nuevas composiciones a base de taxoides. |